VERTEX PHARMACEUTICALS INC / MA Insider Trading for June 2017
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in VERTEX PHARMACEUTICALS INC / MA.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in VERTEX PHARMACEUTICALS INC / MA for June 2017.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 23 2017 | VRTX | VERTEX PHARMACEUTI ... | Silva Paul M | SVP & Corp Controll ... | Option Exercise | M | 83.36 | 2,577 | 214,819 | 4,297 | |
| Jun 23 2017 | VRTX | VERTEX PHARMACEUTI ... | Silva Paul M | SVP & Corp Controll ... | Sell | S | 133.36 | 2,577 | 343,669 | 20,071 | 22.6 K to 20.1 K (-11.38 %) |
| Jun 23 2017 | VRTX | VERTEX PHARMACEUTI ... | Silva Paul M | SVP & Corp Controll ... | Buy | M | 83.36 | 2,577 | 214,819 | 22,648 | 20.1 K to 22.6 K (+12.84 %) |
| Jun 23 2017 | VRTX | VERTEX PHARMACEUTI ... | Chodakewitz Jeffrey | EVP GMDA, CMO | Option Exercise | M | 96.87 | 5,157 | 499,559 | 8,594 | |
| Jun 23 2017 | VRTX | VERTEX PHARMACEUTI ... | Chodakewitz Jeffrey | EVP GMDA, CMO | Sell | S | 132.87 | 5,157 | 685,211 | 122,511 | 127.7 K to 122.5 K (-4.04 %) |
| Jun 23 2017 | VRTX | VERTEX PHARMACEUTI ... | Chodakewitz Jeffrey | EVP GMDA, CMO | Buy | M | 96.87 | 5,157 | 499,559 | 127,668 | 122.5 K to 127.7 K (+4.21 %) |
| Jun 09 2017 | VRTX | VERTEX PHARMACEUTI ... | BOGER JOSHUA S | Director | Option Exercise | M | 0.00 | 2,941 | 0 | 0 | |
| Jun 09 2017 | VRTX | VERTEX PHARMACEUTI ... | BOGER JOSHUA S | Director | Buy | M | 0.00 | 2,941 | 0 | 284,088 | 281.1 K to 284.1 K (+1.05 %) |
| Jun 09 2017 | VRTX | VERTEX PHARMACEUTI ... | Garber Alan M | Director | Option Exercise | M | 125.11 | 5,320 | 665,585 | 5,320 | |
| Jun 09 2017 | VRTX | VERTEX PHARMACEUTI ... | Garber Alan M | Director | Grant | A | 0.00 | 2,199 | 0 | 2,199 | 0 to 2.2 K |
| Jun 05 2017 | VRTX | VERTEX PHARMACEUTI ... | ALTSHULER DAVID | EVP, Global Researc ... | Option Exercise | M | 72.14 | 7,500 | 541,050 | 0 | |
| Jun 05 2017 | VRTX | VERTEX PHARMACEUTI ... | ALTSHULER DAVID | EVP, Global Researc ... | Sell | S | 130.00 | 7,500 | 975,000 | 106,011 | 113.5 K to 106 K (-6.61 %) |
| Jun 05 2017 | VRTX | VERTEX PHARMACEUTI ... | ALTSHULER DAVID | EVP, Global Researc ... | Buy | M | 72.14 | 7,500 | 541,050 | 113,511 | 106 K to 113.5 K (+7.07 %) |
| Jun 05 2017 | VRTX | VERTEX PHARMACEUTI ... | Silva Paul M | SVP & Corp Controll ... | Option Exercise | M | 77.31 | 3,867 | 298,958 | 10,312 | |
| Jun 05 2017 | VRTX | VERTEX PHARMACEUTI ... | Silva Paul M | SVP & Corp Controll ... | Sell | S | 127.31 | 3,867 | 492,308 | 20,071 | 23.9 K to 20.1 K (-16.15 %) |
| Jun 05 2017 | VRTX | VERTEX PHARMACEUTI ... | Silva Paul M | SVP & Corp Controll ... | Buy | M | 77.31 | 3,867 | 298,958 | 23,938 | 20.1 K to 23.9 K (+19.27 %) |
| Jun 05 2017 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, CRO | Option Exercise | M | 51.75 | 30,500 | 1,578,375 | 0 | |
| Jun 05 2017 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, CRO | Sell | S | 125.00 | 30,500 | 3,812,500 | 99,335 | 129.8 K to 99.3 K (-23.49 %) |
| Jun 05 2017 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, CRO | Buy | M | 51.75 | 30,500 | 1,578,375 | 129,835 | 99.3 K to 129.8 K (+30.70 %) |
| Jun 05 2017 | VRTX | VERTEX PHARMACEUTI ... | Chodakewitz Jeffrey | EVP GMDA, CMO | Option Exercise | M | 96.87 | 5,155 | 499,365 | 18,908 | |
| Jun 05 2017 | VRTX | VERTEX PHARMACEUTI ... | Chodakewitz Jeffrey | EVP GMDA, CMO | Sell | S | 126.87 | 5,155 | 654,015 | 122,511 | 127.7 K to 122.5 K (-4.04 %) |
| Jun 05 2017 | VRTX | VERTEX PHARMACEUTI ... | Chodakewitz Jeffrey | EVP GMDA, CMO | Buy | M | 96.87 | 5,155 | 499,365 | 127,666 | 122.5 K to 127.7 K (+4.21 %) |
| Jun 05 2017 | VRTX | VERTEX PHARMACEUTI ... | Arbuckle Stuart A | EVP\Chief Commercia ... | Option Exercise | M | 83.36 | 31,875 | 2,657,100 | 2,125 | |
| Jun 05 2017 | VRTX | VERTEX PHARMACEUTI ... | Arbuckle Stuart A | EVP\Chief Commercia ... | Option Exercise | M | 77.31 | 25,500 | 1,971,405 | 12,750 | |
| Jun 05 2017 | VRTX | VERTEX PHARMACEUTI ... | Arbuckle Stuart A | EVP\Chief Commercia ... | Option Exercise | M | 53.74 | 13,594 | 730,542 | 0 | |
| Jun 05 2017 | VRTX | VERTEX PHARMACEUTI ... | Arbuckle Stuart A | EVP\Chief Commercia ... | Sell | S | 129.02 | 57,375 | 7,402,523 | 131,467 | 188.8 K to 131.5 K (-30.38 %) |
| Jun 05 2017 | VRTX | VERTEX PHARMACEUTI ... | Arbuckle Stuart A | EVP\Chief Commercia ... | Buy | M | 83.36 | 31,875 | 2,657,100 | 188,842 | 157 K to 188.8 K (+20.31 %) |
| Jun 05 2017 | VRTX | VERTEX PHARMACEUTI ... | Arbuckle Stuart A | EVP\Chief Commercia ... | Buy | M | 77.31 | 25,500 | 1,971,405 | 156,967 | 131.5 K to 157 K (+19.40 %) |
| Jun 05 2017 | VRTX | VERTEX PHARMACEUTI ... | Arbuckle Stuart A | EVP\Chief Commercia ... | Sell | S | 124.00 | 13,594 | 1,685,656 | 131,467 | 145.1 K to 131.5 K (-9.37 %) |
| Jun 05 2017 | VRTX | VERTEX PHARMACEUTI ... | Arbuckle Stuart A | EVP\Chief Commercia ... | Buy | M | 53.74 | 13,594 | 730,542 | 145,061 | 131.5 K to 145.1 K (+10.34 %) |
| Jun 05 2017 | VRTX | VERTEX PHARMACEUTI ... | SMITH IAN F | EVP, CFO & COO | Option Exercise | M | 38.80 | 10,195 | 395,566 | 0 | |
| Jun 05 2017 | VRTX | VERTEX PHARMACEUTI ... | SMITH IAN F | EVP, CFO & COO | Option Exercise | M | 51.75 | 9,062 | 468,959 | 0 | |
| Jun 05 2017 | VRTX | VERTEX PHARMACEUTI ... | SMITH IAN F | EVP, CFO & COO | Option Exercise | M | 37.86 | 23,789 | 900,652 | 0 | |
| Jun 05 2017 | VRTX | VERTEX PHARMACEUTI ... | SMITH IAN F | EVP, CFO & COO | Option Exercise | M | 48.74 | 18,124 | 883,364 | 0 | |
| Jun 05 2017 | VRTX | VERTEX PHARMACEUTI ... | SMITH IAN F | EVP, CFO & COO | Option Exercise | M | 45.11 | 37,383 | 1,686,347 | 0 | |
| Jun 05 2017 | VRTX | VERTEX PHARMACEUTI ... | SMITH IAN F | EVP, CFO & COO | Sell | S | 124.00 | 98,553 | 12,220,572 | 126,238 | 224.8 K to 126.2 K (-43.84 %) |
| Jun 05 2017 | VRTX | VERTEX PHARMACEUTI ... | SMITH IAN F | EVP, CFO & COO | Buy | M | 38.80 | 10,195 | 395,566 | 224,791 | 214.6 K to 224.8 K (+4.75 %) |
| Jun 05 2017 | VRTX | VERTEX PHARMACEUTI ... | SMITH IAN F | EVP, CFO & COO | Buy | M | 51.75 | 9,062 | 468,959 | 214,596 | 205.5 K to 214.6 K (+4.41 %) |
| Jun 05 2017 | VRTX | VERTEX PHARMACEUTI ... | SMITH IAN F | EVP, CFO & COO | Buy | M | 37.86 | 23,789 | 900,652 | 205,534 | 181.7 K to 205.5 K (+13.09 %) |
| Jun 05 2017 | VRTX | VERTEX PHARMACEUTI ... | SMITH IAN F | EVP, CFO & COO | Buy | M | 48.74 | 18,124 | 883,364 | 181,745 | 163.6 K to 181.7 K (+11.08 %) |
| Jun 05 2017 | VRTX | VERTEX PHARMACEUTI ... | SMITH IAN F | EVP, CFO & COO | Buy | M | 45.11 | 37,383 | 1,686,347 | 163,621 | 126.2 K to 163.6 K (+29.61 %) |
| Jun 05 2017 | VRTX | VERTEX PHARMACEUTI ... | LEIDEN JEFFREY M | CEO & President | Option Exercise | M | 29.98 | 124,601 | 3,735,538 | 0 | |
| Jun 05 2017 | VRTX | VERTEX PHARMACEUTI ... | LEIDEN JEFFREY M | CEO & President | Option Exercise | M | 53.85 | 22,500 | 1,211,625 | 0 | |
| Jun 05 2017 | VRTX | VERTEX PHARMACEUTI ... | LEIDEN JEFFREY M | CEO & President | Sell | S | 129.50 | 147,101 | 19,049,580 | 289,642 | 436.7 K to 289.6 K (-33.68 %) |
| Jun 05 2017 | VRTX | VERTEX PHARMACEUTI ... | LEIDEN JEFFREY M | CEO & President | Buy | M | 29.98 | 124,601 | 3,735,538 | 436,743 | 312.1 K to 436.7 K (+39.92 %) |
| Jun 05 2017 | VRTX | VERTEX PHARMACEUTI ... | LEIDEN JEFFREY M | CEO & President | Buy | M | 53.85 | 22,500 | 1,211,625 | 312,142 | 289.6 K to 312.1 K (+7.77 %) |
| Jun 05 2017 | VRTX | VERTEX PHARMACEUTI ... | YOUNG WILLIAM D | Director | Option Exercise | M | 125.71 | 5,295 | 665,634 | 5,295 | |
| Jun 05 2017 | VRTX | VERTEX PHARMACEUTI ... | YOUNG WILLIAM D | Director | Grant | A | 0.00 | 2,188 | 0 | 5,129 | 2.9 K to 5.1 K (+74.40 %) |
| Jun 05 2017 | VRTX | VERTEX PHARMACEUTI ... | ULLIAN ELAINE | Director | Option Exercise | M | 125.71 | 5,295 | 665,634 | 5,295 | |
| Jun 05 2017 | VRTX | VERTEX PHARMACEUTI ... | ULLIAN ELAINE | Director | Grant | A | 0.00 | 2,188 | 0 | 10,394 | 8.2 K to 10.4 K (+26.66 %) |
| Jun 05 2017 | VRTX | VERTEX PHARMACEUTI ... | SACHS BRUCE I | Director | Option Exercise | A | 0.00 | 2,941 | 0 | 5,275 | |
| Jun 05 2017 | VRTX | VERTEX PHARMACEUTI ... | SACHS BRUCE I | Director | Option Exercise | A | 125.71 | 5,295 | 665,634 | 5,295 | |
| Jun 05 2017 | VRTX | VERTEX PHARMACEUTI ... | SACHS BRUCE I | Director | Sell | D | 0.00 | 2,941 | 0 | 23,398 | 26.3 K to 23.4 K (-11.17 %) |
| Jun 05 2017 | VRTX | VERTEX PHARMACEUTI ... | SACHS BRUCE I | Director | Grant | A | 0.00 | 2,188 | 0 | 26,339 | 24.2 K to 26.3 K (+9.06 %) |
| Jun 05 2017 | VRTX | VERTEX PHARMACEUTI ... | MCGLYNN MARGARET G | Director | Option Exercise | M | 125.71 | 5,295 | 665,634 | 5,295 | |
| Jun 05 2017 | VRTX | VERTEX PHARMACEUTI ... | MCGLYNN MARGARET G | Director | Grant | A | 0.00 | 2,188 | 0 | 6,217 | 4 K to 6.2 K (+54.31 %) |
| Jun 05 2017 | VRTX | VERTEX PHARMACEUTI ... | Lee Yuchun | Director | Option Exercise | M | 125.71 | 5,295 | 665,634 | 5,295 | |
| Jun 05 2017 | VRTX | VERTEX PHARMACEUTI ... | Lee Yuchun | Director | Sell | S | 128.44 | 1,323 | 169,926 | 4,847 | 6.2 K to 4.8 K (-21.44 %) |
| Jun 05 2017 | VRTX | VERTEX PHARMACEUTI ... | Lee Yuchun | Director | Grant | A | 0.00 | 2,188 | 0 | 6,170 | 4 K to 6.2 K (+54.95 %) |
| Jun 05 2017 | VRTX | VERTEX PHARMACEUTI ... | Kearney Terrence C | Director | Option Exercise | M | 125.71 | 5,295 | 665,634 | 5,295 | |
| Jun 05 2017 | VRTX | VERTEX PHARMACEUTI ... | Kearney Terrence C | Director | Grant | A | 0.00 | 2,188 | 0 | 6,629 | 4.4 K to 6.6 K (+49.27 %) |
| Jun 05 2017 | VRTX | VERTEX PHARMACEUTI ... | BOGER JOSHUA S | Director | Option Exercise | A | 0.00 | 2,941 | 0 | 2,941 | |
| Jun 05 2017 | VRTX | VERTEX PHARMACEUTI ... | BOGER JOSHUA S | Director | Option Exercise | A | 125.71 | 5,295 | 665,634 | 5,295 | |
| Jun 05 2017 | VRTX | VERTEX PHARMACEUTI ... | BOGER JOSHUA S | Director | Sell | D | 0.00 | 2,941 | 0 | 281,147 | 284.1 K to 281.1 K (-1.04 %) |
| Jun 05 2017 | VRTX | VERTEX PHARMACEUTI ... | BOGER JOSHUA S | Director | Grant | A | 0.00 | 2,188 | 0 | 284,088 | 281.9 K to 284.1 K (+0.78 %) |
| Jun 05 2017 | VRTX | VERTEX PHARMACEUTI ... | Bhatia Sangeeta N. | Director | Option Exercise | M | 125.71 | 5,295 | 665,634 | 5,295 | |
| Jun 05 2017 | VRTX | VERTEX PHARMACEUTI ... | Bhatia Sangeeta N. | Director | Sell | S | 128.44 | 1,176 | 151,045 | 3,953 | 5.1 K to 4 K (-22.93 %) |
| Jun 05 2017 | VRTX | VERTEX PHARMACEUTI ... | Bhatia Sangeeta N. | Director | Grant | A | 0.00 | 2,188 | 0 | 5,129 | 2.9 K to 5.1 K (+74.40 %) |